Mackenzie Financial
CKPT

Mackenzie Financial’s Checkpoint Therapeutics CKPT Stock Holding History

Mackenzie Financial’s Portfolio CKPT Stock Details CKPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,077
Closed -$16K – 1029
2020
Q1 		$16K Buy
+1,077
New +$19.1K ﹤0.01% 1062

Other funds holding CKPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Mackenzie Financial's CKPT Position: Q2 2020 in Review

Mackenzie Financial sold out of Checkpoint Therapeutics (CKPT) in Q2 2020, closing a stake of 1,077 shares — an estimated $16K sold.

Mackenzie Financial first reported a position in CKPT in Q1 2020 and held it in 1 quarter. The position peaked at $16K in Q1 2020. 45 funds tracked by Wall St. Rank hold CKPT as of Q2 2020.

  • Mackenzie Financial reported no remaining Checkpoint Therapeutics position as of Q2 2020 after selling out during the quarter.
  • Mackenzie Financial sold 1,077 Checkpoint Therapeutics shares in Q2 2020, an estimated $16K.
  • Mackenzie Financial first reported a position in Checkpoint Therapeutics in Q1 2020 and held it in 1 quarter.
  • Mackenzie Financial's Checkpoint Therapeutics position peaked at $16K in Q1 2020.
  • 45 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q2 2020.

Based on Mackenzie Financial's 13F filing for Q2 2020, filed 13 Aug 2020.